Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

Blood-Based Testing for Advanced Adenoma 5U01CA271884-04 Matthew Young, Ph.D.
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 5R37CA275916-03 Claire Zhu, Ph.D.
Schuetze, Scott Michael

University Of Michigan At Ann Arbor
United States

Early Phase Clinical Cancer Prevention Consortium 2UG1CA242632-06 Donald Johnsey
Sears, Rosalie C

Oregon Health & Science University
United States

An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals 4U01CA294548-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sears, Rosalie C

Oregon Health & Science University
United States

Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs 5U01CA278923-03 Matthew Young, Ph.D.
Sedrak, Mina S

University Of California Los Angeles
United States

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H.
Sedrak, Mina S

University Of California Los Angeles
United States

Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline 5R01CA280088-03 Goli Samimi, Ph.D., M.P.H.
Sedrak, Mina S

University Of California Los Angeles
United States

Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors 5R21CA277660-03 Goli Samimi, Ph.D., M.P.H.
Sedrak, Mina S

University Of California Los Angeles
United States

Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors 5R21CA277660-03 Goli Samimi, Ph.D., M.P.H.
Segal, Leopoldo Nicolas

New York University School Of Medicine
United States

Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer 5U2CCA271890-03 Guillermo Marquez, Ph.D.
Segata, Nicola

University Of Trento
United States

PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS) 1OT2CA297205-01 Asad Umar, D.V.M., Ph.D.
Seguin-Fowler, Rebecca Anne

Texas A&M Agrilife Research
United States

Deep in the Heart for Women: A Community-Engaged Intervention Study to Catalyze a Culture of Health in Rural South Texas 1R01HL179449-01 Goli Samimi, Ph.D., M.P.H.
Semmes, Oliver John

Old Dominion University
United States

Virginia-UCLA-Toronto Biomarker Characterization Center 5U2CCA271894-05 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sempere, Lorenzo

Michigan State University
United States

Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer 5R01CA258314-04 Edward Sauter, M.D., Ph.D.
Sen, Subrata

University Of Tx Md Anderson Can Ctr
United States

Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer 5U01CA214263-07 Matthew Young, Ph.D.